Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT05619848

Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery (RUILS)

Sponsor: Zheng Guo

Updated 4 times since 2022 Last updated: Feb 14, 2023 Started: Oct 25, 2022 Primary completion: Dec 27, 2022 Completion: Dec 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05619848, this EARLY_PHASE1 trial focuses on Spinal Stenosis Lumbar and remains completed. Sponsored by Zheng Guo, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Mar 2023 — Jul 2024 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Dec 2022 — Mar 2023 [monthly]

Recruiting EARLY_PHASE1

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zheng Guo

Data source: Second Hospital of Shanxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taiyuan, China